Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03322891 · ClinicalTrials.gov registry record · NA

Improving Health Literacy in African-American Prostate Cancer Patients

A NA study of Prostate Cancer, sponsored by Emory University.

Recruiting
Registry status
NA
Development phase
210
Enrollment target
4
Study locations

NCT03322891 is a NA study of Prostate Cancer that is actively recruiting participants, run by Emory University. The registered enrollment target is 210 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (65% lower). The trial reports 4 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03322891, a NA study of Prostate Cancer, is actively recruiting participants, sponsored by Emory University.

RECRUITING
Registry status
NA
Development phase
210 participants
Enrollment target
4
Study locations

Study Summary

Investigators propose an observational interview study to explore how patients understand treatment conversations with their physicians within the framework of health literacy. The study team will test whether patients' understanding of treatment options and side effects can be improved when patients receive a low literacy educational supplement after meeting with their urologist. Investigators will interview a group of newly diagnosed, early stage, African American prostate cancer patients.

Conditions Studied

Prostate Cancer

Interventions

  • OTHER Educational Supplement
  • OTHER Standard Practice Education

Study Locations (4)

Georgia

  • Atlanta VA Medical Center - Atlanta
  • Grady Memorial Hospital - Atlanta
  • Emory University - Atlanta
  • Emory Saint Joseph's Hospital - Atlanta

Trial Details

FieldValue
Enrollment Target 210 participants
Start Date 2016-07-21
Est. Completion 2027-03-31
Phase NA

Sponsor

Emory University

1,208 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03322891

The ClinicalTrials.gov registry entry for NCT03322891 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 210 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (65% lower). The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 2 interventions - of which Educational Supplement is the first listed.

NCT03322891 reports 4 study locations spanning 1 distinct geographic area - top geographies include Georgia.

Frequently Asked Questions

What is clinical trial NCT03322891 about?

NCT03322891 is a clinical study titled "Improving Health Literacy in African-American Prostate Cancer Patients". Investigators propose an observational interview study to explore how patients understand treatment conversations with their physicians within the framework of health literacy. The study team will test whether patients' understanding of treatment options and side effects can be improved when patient...

What is the current status of trial NCT03322891?

This trial is currently recruiting. It is a NA study. The enrollment target is 210 participants. The study started on 2016-07-21. Estimated completion is 2027-03-31.

What conditions does trial NCT03322891 study?

This clinical trial studies the following conditions: Prostate Cancer.

What interventions are being tested in trial NCT03322891?

The interventions under investigation include: Educational Supplement (OTHER), Standard Practice Education (OTHER).

Who is sponsoring clinical trial NCT03322891?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03322891 being conducted?

This trial has 4 study locations across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Prostate Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Prostate Cancer

All registered trials for this condition

Georgia

All trials with a study site in Georgia

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.